Short-term Menstrual Distributions After COVID-19 Infection: Does Vaccine Administration Matter?
Fertility, Gynecology and Andrology · 2022
DOI: 10.5812/fga-131433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fertility, Gynecology and Andrology, 2022. Verfasst von Sedigheh Hantoushzadeh und 10 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
COVID-19 infection may be associated with potential sequels on the hormonal system, which can substantially alter menstrual cycles in women.
Objectives
This study aimed to evaluate short-term menstrual distributions after COVID-19 infection and determine whether vaccination and type of vaccine could alter menstrual cycles.
Methods
This study was carried out using an online survey to record any menstrual distributions such as any changes in duration, volume, and time of menstruation, intermenstrual bleeding (IMB) and dysmenorrhea as well as exacerbation of premenstrual syndrome (PMS) on 268 women aged 18 to 45 who were infected by COVID-19. The participants were followed at least for three months after their COVID-19 infection. The history of vaccine administration before infection was also recorded, and the results were compared regarding various vaccine types.
Results
Short-term menstrual distributions after infection were common. in this regard46.7% had IMB, 66.1% experienced exacerbation in PMS, 67.7% had increased volume of bleeding, 62.9% had dysmenorrhea or exacerbation in dysmenorrhea. Also, 27.4% and 35.4% experienced a shorter or longer duration of menstrual cycles, respectively. All distributions returned to normal after a maximum of two cycles. However, there was a substantial difference (P = 0.024) between women who received the AstraZeneca (recombinant) and Sinopharm (inactivated) vaccines, as the number of patients who experienced changes in menstrual cycles was relatively lower in the recombinant group.
Conclusions
Menstrual distributions are common but temporary in the short term following COVID-19 infection. Although, the recombinant vaccine (AstraZeneca) was associated with lower menstrual disturbance rates compared to Sinopharm or Sputnik vaccines.
Zitieren
APA
Hantoushzadeh, S., Taheri, M., Hadizadeh, A., Sharif, P. M., Fakehi, M., Hajari, P., Heidary, Z., Asadi, F., Akbari, R., Hashemnejad, M. M., & Ghaemi, M. (2022). Short-term Menstrual Distributions After COVID-19 Infection: Does Vaccine Administration Matter?. Fertility, Gynecology and Andrology. https://doi.org/10.5812/fga-131433
Vancouver
Hantoushzadeh S, Taheri M, Hadizadeh A, Sharif PM, Fakehi M, Hajari P, et al. Short-term Menstrual Distributions After COVID-19 Infection: Does Vaccine Administration Matter?. Fertility, Gynecology and Andrology. 2022. doi:10.5812/fga-131433
BibTeX
@article{Hantoushzadeh2022,
author = {Hantoushzadeh, Sedigheh and Taheri, Minoo and Hadizadeh, Alireza and Sharif, Pooya Mahdavi and Fakehi, Malihe and Hajari, Parisa and Heidary, Zohreh and Asadi, Fatemeh and Akbari, Razieh and Hashemnejad, Mohammad Mehdi and Ghaemi, Marjan},
title = {Short-term Menstrual Distributions After COVID-19 Infection: Does Vaccine Administration Matter?},
journal = {Fertility, Gynecology and Andrology},
year = {2022},
doi = {10.5812/fga-131433}
}
EUVIMED